Stocks
Arcutis Biotherapeutics, Inc.ARQT
NASDAQHealthcareBiotechnology$22.75-0.70%
Focused on medical dermatology, this biotechnology company develops and commercializes topical therapies for inflammatory skin diseases such as psoriasis, seborrheic dermatitis, and atopic dermatitis. Its lead products are based on roflumilast, a PDE4 inhibitor formulated for creams and foams aimed ...
Market Cap: $2.8B52W Range: $11.86 – $31.77
Congressional Interest in Arcutis Biotherapeutics, Inc. (ARQT)
1 member of Congress has disclosed 3 trades in Arcutis Biotherapeutics, Inc. (ARQT), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
2
Sells
1
Who in Congress Is Trading ARQT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2023-04-17 | Josh Gottheimer | buy | $1K – $15K |